Navigation Links
Europe's R&D leaders assembled in Eilat agree to invest $46 million in joint R&D initiatives
Date:3/1/2011

February 27, 2011 Eilat, Israel Assembled in Eilat in southern Israel for the second event held in Israel under the Israeli EUREKA Chairmanship, EUREKA's High Level Group Representatives and National Project Coordinators approved a series of promising cooperative R&D projects in several fields, including renewable energy, agrofood technology, biotechnology, physical and exact sciences, IT and electronics, industrial manufacturing, and more.

During the EUREKA meeting, held in parallel to and in cooperation with the 2011 Eilat-Eilot Renewable Energy Conference, EUREKA's decision-makers approved 25 viable technologies and products through the EUREKA programme, totalling 33 million euro of investment. Six of the 25 projects approved under EUREKA's individual projects programme have Israeli partners representing almost 25% of the total. Remarkably, Israel is only one of 40 member countries in EUREKA but represents just under one-quarter of the individual project proposals approved during this meeting.

These projects add to more than 150 EUREKA and Eurostars projects already approved since Israel took the leadership of EUREKA, totalling more than 150 million euro of private and public investment. Altogether Israeli companies take part in nearly 15% of all EUREKA and Eurostars projects, which support small and medium sized companies.

EUREKA currently has over 100 active clean-tech projects, at a cost of just under 200 million Euro. In the spirit of promoting further innovation in clean technology, during the event EUREKA marked the launch of its new EUREKA Clean-Tech Action, a campaign focused on generating cooperative industrial R&D projects in the cleantech sector.

Israeli NPC (National Project Coordinators) Chairman Israel Shamay comments: "When launching the EUREKA Clean-Tech Action, we set a very ambitious goal to mobilize all available EUREKA instruments in order to generate and support clean-tech projects. The fact is that dozens of innovative companies from EUREKA's member countries, as well as ALL the EUREKA clusters which incorporate Europe's industrial market leaders are attending the meetings in Eilat. This is the real proof of concept for the rationale and necessity of the Clean-tech Action initiated by the Israeli EUREKA Chairmanship".

EUREKA delegates, representing government agencies from over 40 countries, gathered at the meetings to promote industry, technology, R&D, and international cooperation through funding and partner-matching. During the conference they strategized on how best to meet the global needs of today and tomorrow, such as climate change, reducing greenhouse gas emissions, deploying smart grids, expanding solar and wind energy zoning, overcoming water shortages and more.

On a yearly basis, EUREKA supports more than 300 collaborative projects in a variety of industries, totalling over 1.5 billion Euro. These industrial projects match up partners from two or more member countries including small and medium-sized enterprises (SMEs), large industry, and research institutes. Projects can be launched in virtually all industry fields and technological areas IT, manufacturing, water technologies, communications, biotechnology and energy, among others. EUREKA initiatives look to meet challenges such as climate change, energy security, and limited water resources.

Israel's chairmanship of EUREKA is being led by former Chief Scientist Dr. Eli Opper and the Israeli Ministry of Industry and Trade, through MATIMOP the Israeli Industry Center for Research and Development, which is the executive agency of the Chief Scientist's office. The Israeli leadership of EUREKA will provide an opportunity to showcase Israel's culture of innovation and entrepreneurship. Indeed, at the ripe of age of 62, Israel has been coined the "start-up nation" of the world. With over 3,800 technology-based start-up companies, innovation has become a key factor in the country's economic stability and success assets reflected in its participation in EUREKA projects. From all of EUREKA's 40 member countries, Israel is actually one of EUREKA's most active participants. The Chairmanship provides enormous opportunities for Israeli and European companies and highlights Israel's unique contributions to European innovation and R&D.


'/>"/>

Contact: Piotr Pogorzelski
piotr.pogorzelski@eurekanetwork.org
322-777-0979
EUREKA
Source:Eurekalert

Related biology news :

1. Ben-Gurion U. and PTT Chemical sign R&D agreement to commercialize green algae strain
2. European R&D leaders assembled in Tel Aviv will invest $70 million in joint R&D initiatives
3. Digital data forensic expert at NJIT to be feted by R&D council for data hiding patents
4. Changes in energy R&D needed to combat climate change
5. Israeli Minister of Industry and Trade to address European R&D leaders in Tel Aviv
6. Kemira and VTT to open a joint R&D center in Brazil
7. American Chemical Society, Council for Chemical Research to hold R&D symposium Aug. 22
8. PNNL scientists win 4 R&D 100 awards for environment, biology, security technologies
9. Workshop on R&D for rapid vaccine development and production in Asia/Australia
10. Innovative R&D prioritization tool earns Baxter the 2009 INFORMS Decision Analysis Award
11. MINDEF, NTU join hands to boost Singapores defense R&D capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
(Date:2/23/2017)... SAN JOSE, Calif. , Feb. 23, 2017 ... an exclusive license for two key immunotherapy technologies ... The first technology provides a method to monitor ... therapy such as PD-L1 and CTLA-4.  The second ... detect if a patient is likely to have ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... in a published evaluation of multiple immunoassay-based threat detection technologies by researchers ... Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have the ...
(Date:2/23/2017)... 23, 2017 Aviva Systems Biology Corporation ... acquisition of GenWay Biotech Incorporated, a protein solutions ... product offering for both the research and diagnostic ... and enhance capabilities for both entities. GenWay,s 18 years ... will nicely complement ASB,s objective to become a ...
Breaking Biology Technology: